Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
Elite Pharmaceuticals Inc. (ELTP) had Profit Margin of 30.14% for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
$148.87M |
|
$44.87M |
|
$73.85M |
|
$75.02M |
|
$99.76M |
|
$49.11M |
|
$7.70M |
|
$56.81M |
|
$56.81M |
|
$44.87M |
|
$44.87M |
|
$44.87M |
|
$44.87M |
|
$49.11M |
|
$51.15M |
|
1.07B |
|
1.14B |
|
$0.04 |
|
$0.03 |
|
| Balance Sheet Financials | |
$112.11M |
|
$10.18M |
|
$26.18M |
|
$138.29M |
|
$17.39M |
|
$3.66M |
|
$22.02M |
|
$39.41M |
|
$98.88M |
|
$94.09M |
|
$98.88M |
|
1.08B |
|
| Cash Flow Statement Financials | |
$23.75M |
|
$-0.93M |
|
$-4.32M |
|
$11.77M |
|
$30.27M |
|
$18.50M |
|
$0.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.45 |
|
-- |
|
-- |
|
0.04 |
|
0.04 |
|
50.40% |
|
32.99% |
|
32.99% |
|
34.36% |
|
38.16% |
|
|
Profit Margin |
30.14% |
$22.82M |
|
-- |
|
-- |
|
-- |
|
1.08 |
|
3.47 |
|
2.49 |
|
146.41 |
|
45.38% |
|
47.69% |
|
32.45% |
|
43.76% |
|
$0.09 |
|
$0.02 |
|
$0.02 |
|